[
  {
    "ts": "2025-12-11T13:00:00+00:00",
    "headline": "Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort",
    "summary": "WILMINGTON, Mass., December 11, 2025--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort announced in April 2025, the program provides early-stage biotechnology pioneers with access to extensive scientific and commercial expertise, as well as a comprehensive ecosystem of discovery, development, and manufacturing capabilities, to expedite the developme",
    "url": "https://finance.yahoo.com/news/charles-river-extends-commitment-advanced-130000376.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "51bc71b0-465c-3405-a864-29e92687d8e7",
      "content": {
        "id": "51bc71b0-465c-3405-a864-29e92687d8e7",
        "contentType": "STORY",
        "title": "Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort",
        "description": "",
        "summary": "WILMINGTON, Mass., December 11, 2025--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the second cohort of its Cell & Gene Therapy Incubator Program (CIP). Launched in December 2024, with the inaugural cohort announced in April 2025, the program provides early-stage biotechnology pioneers with access to extensive scientific and commercial expertise, as well as a comprehensive ecosystem of discovery, development, and manufacturing capabilities, to expedite the developme",
        "pubDate": "2025-12-11T13:00:00Z",
        "displayTime": "2025-12-11T13:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/e31c7546c10bcda06c9262554961c999",
          "originalWidth": 1245,
          "originalHeight": 326,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xG4H86ldenqT6wEqBPhZ6w--~B/aD0zMjY7dz0xMjQ1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/e31c7546c10bcda06c9262554961c999.cf.webp",
              "width": 1245,
              "height": 326,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/r5sA58qfLtcoLCaaDuLBhA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/e31c7546c10bcda06c9262554961c999.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-extends-commitment-advanced-130000376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-extends-commitment-advanced-130000376.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]